AAAAAA

   
Results: 1-7 |
Results: 7
ChlVPP alternating with PABIOE is superior to PABIOE alone in the initial treatment of advanced Hodgkin's disease: results of a British National Lymphoma Investigation/Central Lymphoma Group randomized controlled trial
Authors: Hancock, BW Gregory, WM Cullen, MH Hudson, GV Burton, A Selby, P Maclennan, KA Jack, A Bessell, EM Smith, P Linch, DC
Citation: Bw. Hancock et al., ChlVPP alternating with PABIOE is superior to PABIOE alone in the initial treatment of advanced Hodgkin's disease: results of a British National Lymphoma Investigation/Central Lymphoma Group randomized controlled trial, BR J CANC, 84(10), 2001, pp. 1293-1300
Chemotherapy versus palliative care in non-small cell lung cancer
Authors: Nicum, S Cullen, MH
Citation: S. Nicum et Mh. Cullen, Chemotherapy versus palliative care in non-small cell lung cancer, ANTI-CANC D, 11(8), 2000, pp. 603-607
A Medical Research Council randomized trial of single agent carboplatin versus etoposide and cisplatin for advanced metastatic seminoma
Authors: Horwich, A Oliver, RTD Wilkinson, PM Mead, GM Harland, SJ Cullen, MH Roberts, JT Fossa, SD Dearnaley, DP Lallemand, E Stenning, SP
Citation: A. Horwich et al., A Medical Research Council randomized trial of single agent carboplatin versus etoposide and cisplatin for advanced metastatic seminoma, BR J CANC, 83(12), 2000, pp. 1623-1629
Pharmacokinetic study of single doses of oral fludarabine phosphate in patients with "low-grade" non-Hodgkin's lymphoma and B-cell chronic lymphocytic leukemia
Authors: Foran, JM Oscier, D Orchard, J Johnson, SA Tighe, M Cullen, MH de Takats, PG Kraus, C Klein, M Lister, TA
Citation: Jm. Foran et al., Pharmacokinetic study of single doses of oral fludarabine phosphate in patients with "low-grade" non-Hodgkin's lymphoma and B-cell chronic lymphocytic leukemia, J CL ONCOL, 17(5), 1999, pp. 1574-1579
Optimal planning target volume for stage I testicular seminoma: A medical research council randomized trial
Authors: Fossa, SD Horwich, A Russell, JM Roberts, JT Cullen, MH Hodson, NJ Jones, WG Yosef, H Duchesne, GM Owen, JR Grosch, EJ Chetiyawardana, AD Reed, NS Widmer, B Stenning, SP
Citation: Sd. Fossa et al., Optimal planning target volume for stage I testicular seminoma: A medical research council randomized trial, J CL ONCOL, 17(4), 1999, pp. 1146-1154
Mitomycin, ifosfamide, and cisplatin in unresectable non-small-cell lung cancer: Effects on survival and quality of life
Authors: Cullen, MH Billingham, LJ Woodroffe, CM Chetiyawardana, AD Gower, NH Joshi, R Ferry, DR Rudd, RM Spiro, SG Cook, JE Trask, C Bessell, E Connolly, CK Tobias, J Souhami, RL
Citation: Mh. Cullen et al., Mitomycin, ifosfamide, and cisplatin in unresectable non-small-cell lung cancer: Effects on survival and quality of life, J CL ONCOL, 17(10), 1999, pp. 3188-3194
Prognostic factors in patients progressing after cisplatin based chemotherapy for malignant non-seminomatous germ cell tumours
Authors: Fossa, SD Stenning, SP Gerl, A Horwich, A Clark, PI Wilkinson, PM Jones, WG Williams, MV Oliver, RT Newlands, ES Mead, GM Cullen, MH Kaye, SB Rustin, GJS Cook, PA
Citation: Sd. Fossa et al., Prognostic factors in patients progressing after cisplatin based chemotherapy for malignant non-seminomatous germ cell tumours, BR J CANC, 80(9), 1999, pp. 1392-1399
Risultati: 1-7 |